Author:
Smith Kiersten S.,Rudolph Uwe
Funder
National Institutes of Health
Subject
Cellular and Molecular Neuroscience,Pharmacology
Reference67 articles.
1. Adinazolam, a new triazolobenzodiazepine, and imipramine in the treatment of major depressive disorder;Amsterdam;Psychopharmacology,1986
2. GABAA receptor α2/α3 subtype-selective modulators as potential nonsedating anxiolytics;Atack;Current Topics in Behavioral Neurosciences,2010
3. Anxiogenic properties of an inverse agonist selective for alpha3 subunit-containing GABA A receptors;Atack;British Journal of Pharmacology,2005
4. TPA023 [7-(1,1-dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates;Atack;Journal of Pharmacology & Experimental Therapeutics,2006
5. A model of anxious depression: persistence of behavioral pathology;Avgustinovich;Neuroscience & Behavioral Physiology,2005
Cited by
101 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献